Distinct Phases of Blood Gene Expression Pattern Through Tuberculosis Treatment Reflect Modulation of the Humoral Immune Response
Open Access
- 7 August 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 207 (1) , 18-29
Abstract
Background. Accurate assessment of treatment efficacy would facilitate clinical trials of new antituberculosis drugs. We hypothesized that early alterations in peripheral immunity could be measured by gene expression profiling in tuberculosis patients undergoing successful conventional combination treatment. Methods. Ex vivo blood samples from 27 pulmonary tuberculosis patients were assayed at diagnosis and during treatment. RNA was processed and hybridized to Affymetrix GeneChips, to determine expression of over 47 000 transcripts. Results. There were significant ≥2-fold changes in expression of >4000 genes during treatment. Rapid, large-scale changes were detected, with down-regulated expression of 1261 genes within the first week, including inflammatory markers such as complement components C1q and C2. This was followed by slower changes in expression of different networks of genes, including a later increase in expression of B-cell markers, transcription factors, and signaling molecules. Conclusions. The fast initial down-regulation of expression of inflammatory mediators coincided with rapid killing of actively dividing bacilli, whereas slower delayed changes occurred as drugs acted on dormant bacilli and coincided with lung pathology resolution. Measurement of biosignatures during clinical trials of new drugs could be useful predictors of rapid bactericidal or sterilizing drug activity, and would expedite the licensing of new treatment regimens.Keywords
This publication has 38 references indexed in Scilit:
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis PatientsAntimicrobial Agents and Chemotherapy, 2010
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisNature, 2010
- Shortening Treatment in Adults with Noncavitary Tuberculosis and 2-Month Culture ConversionAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Differential LiveMycobacterium tuberculosis-,M. bovisBCG-, Recombinant ESAT6-, and Culture Filtrate Protein 10-Induced Immunity in TuberculosisClinical and Vaccine Immunology, 2009
- How B cells shape the immune response against Mycobacterium tuberculosisEuropean Journal of Immunology, 2009
- Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosisClinical and Experimental Immunology, 2009
- A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus ErythematosusImmunity, 2008
- Gene expression profiles of bronchoalveolar cells in pulmonary TBTuberculosis, 2008
- Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment respondersClinical and Experimental Immunology, 2006